AI assistant
Solana Co — Director's Dealing 2018
May 17, 2018
32724_dirs_2018-05-17_f7c79b96-657f-4623-9a4c-48b4a6f3ae18.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HELIUS MEDICAL TECHNOLOGIES, INC (HSDT)
CIK: 0001610853
Period of Report: 2018-01-10
Reporting Person: Tyler Mitch E (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-10 | Class A Common Stock | J | 829545 | $0.00 | Acquired | 829545 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-05-15 | Stock Option (Right to Buy) | $10.99 | A | 12500 | Acquired | 2028-05-15 | Class A Common Stock (12500) | Direct |
Footnotes
F1: Pro rata distribution from Advanced NeuroRehabilitation, LLC, of which the Reporting Person was a member.
F2: Translated into US dollars from Canadian dollars based on buying rate from Bank of Canada. USD $1.0000 = CAD $1.2876 on May 15, 2018; based on exercise price of CAD $14.15.
F3: Grant to the Reporting Person of a stock option under the Issuer's 2016 Stock Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from May 15, 2018, subject to the Reporting Person's continued service through each applicable vesting date.